108 related articles for article (PubMed ID: 7529926)
1. Effect of tachykinins on the need-free sodium intake of female rats: a continuous intracerebroventricular infusion study.
Polidori C; Ciccocioppo R; Epstein AN; de Caro G; Massi M
Physiol Behav; 1994 Nov; 56(5):877-82. PubMed ID: 7529926
[TBL] [Abstract][Full Text] [Related]
2. The tachykinin NH2-senktide, a selective neurokinin B receptor agonist, is a very potent inhibitor of salt appetite in the rat.
Massi M; Polidori C; Gentili L; Perfumi M; de Caro G; Maggi CA
Neurosci Lett; 1988 Oct; 92(3):341-6. PubMed ID: 2462199
[TBL] [Abstract][Full Text] [Related]
3. Effects of the selective tachykinin NK3 receptor agonist NH2-senktide on intraoral intake and taste reactivity responses elicited by NaCl in sodium-replete rats.
Polidori C; Pompei P; Ciccocioppo R; de Caro G; Massi M
Regul Pept; 1996 Oct; 66(1-2):101-4. PubMed ID: 8899901
[TBL] [Abstract][Full Text] [Related]
4. The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats.
Perfumi M; Polidori C; Pompei PL; De Caro G; Massi M
Pharmacol Biochem Behav; 1991 Apr; 38(4):881-7. PubMed ID: 1714609
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide gamma: a mammalian tachykinin endowed with potent antidipsogenic action in rats.
Polidori C; Staffinati G; Perfumi MC; de Caro G; Massi M
Physiol Behav; 1995 Sep; 58(3):595-602. PubMed ID: 8587970
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of salt appetite in the rat following injection of tachykinins into the medial amygdala.
Massi M; Gentili L; Perfumi M; de Caro G; Schulkin J
Brain Res; 1990 Apr; 513(1):1-7. PubMed ID: 1693538
[TBL] [Abstract][Full Text] [Related]
7. Intraventricular injections of tachykinin NK3 receptor agonists suppress the intake of "salty" tastes by sodium deficient rats.
Flynn FW
Behav Brain Res; 2006 Jan; 166(1):1-8. PubMed ID: 16154648
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of isotonic sodium chloride intake in the rat by selective tachykinin agonists.
Ciccocioppo R; Polidori C; Pompei P; de Caro G; Massi M
Pharmacol Biochem Behav; 1994 Mar; 47(3):609-15. PubMed ID: 8208781
[TBL] [Abstract][Full Text] [Related]
9. Selective agonists at NK3 tachykinin receptors inhibit alcohol intake in Sardinian alcohol-preferring rats.
Ciccocioppo R; Panocka I; Pompei P; De Caro G; Massi M
Brain Res Bull; 1994; 33(1):71-7. PubMed ID: 7506113
[TBL] [Abstract][Full Text] [Related]
10. Further evidence that the tachykinin PG-KII is a potent agonist at central NK-3, but not NK-1, receptors.
Polidori C; Panocka I; Ciccocioppo R; Broccardo M; Improta G; Regoli D; Massi M
Peptides; 1997; 18(6):825-33. PubMed ID: 9285931
[TBL] [Abstract][Full Text] [Related]
11. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
12. Hypotensive effect of intravenous injection of tachykinins in conscious, freely moving spontaneously hypertensive and Wistar Kyoto rats.
Pompei P; Tayebati SJ; Polidori C; Perfumi M; De Caro G; Massi M
Peptides; 1993; 14(1):97-102. PubMed ID: 7680131
[TBL] [Abstract][Full Text] [Related]
13. Central tachykinin injection potently suppresses the need-free salt intake of the female rat.
Massi M; Gentili L; Pompei P; de Caro G; Epstein AN
Brain Res; 1992 Jul; 584(1-2):77-82. PubMed ID: 1325251
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of intraventricular injections of tachykinin NK1 and NK3 receptor agonists on normal and sham drinking of NaCl by sodium-deficient rats.
Flynn FW; Smith ME; Bieber SL
Behav Neurosci; 1999 Aug; 113(4):776-86. PubMed ID: 10495085
[TBL] [Abstract][Full Text] [Related]
15. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
[TBL] [Abstract][Full Text] [Related]
16. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
Roccon A; Marchionni D; Nisato D
Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
[TBL] [Abstract][Full Text] [Related]
17. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism.
Humpel C; Saria A; Regoli D
Eur J Pharmacol; 1991 Mar; 195(1):107-14. PubMed ID: 1712305
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
19. Control of salt intake by steroids and cerebral peptides.
Epstein AN
Pharmacol Res; 1992; 25(2):113-24. PubMed ID: 1635890
[TBL] [Abstract][Full Text] [Related]
20. Bed nucleus of the stria terminalis: site for the antinatriorexic action of tachykinins in the rat.
Pompei P; Tayebaty SJ; De Caro G; Schulkin J; Massi M
Pharmacol Biochem Behav; 1991 Dec; 40(4):977-81. PubMed ID: 1816584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
